RecruitingPhase IIIEN originalBladder cancerMetastatic / advanced

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

Researchers are looking for new ways to treat locally advanced or metastatic urothelial cancer (UC). Current treatments for locally advanced or metastatic UC include chemotherapy, immunotherapy, and targeted therapy. Researchers want to know if giving sacituzumab tirumotecan (sac-TMT), the trial medicine, can treat locally advanced or metastatic UC that got worse after certain treatments. The goal of this trial is to learn if people who receive sac-TMT live longer than those who receive certain non-platinum chemotherapies.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • •Rak pęcherza moczowego, który rozprzestrzenił się lub jest zaawansowany, ale nie nadaje się do leczenia operacyjnego ani napromieniania mającego na celu wyleczenie.
  • •Choroba jest widoczna w badaniach obrazowych.
  • •Otrzymano już pewne leczenia, w tym immunoterapię (anty-PD-(L)1), chemioterapię zawierającą platynę oraz lek enfortumab vedotin.
  • •Otrzymano maksymalnie 2 wcześniejsze linie leczenia.
  • •Choroba nasiliła się po ostatnim zastosowanym leczeniu.
  • •Ogólny stan zdrowia pozwala na udział w badaniu (w skali 0-1).

✗ Disqualifies

  • •Problemy z oczami, które mogą utrudniać gojenie się rogówki.
  • •Nieustabilizowane lub poważne problemy zdrowotne.

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
October 13, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (105)

Sibley Memorial Hospital ( Site 0849)

Washington D.C., United States

Emory University Hospital ( Site 0824)

Atlanta, United States

Johns Hopkins University ( Site 0843)

Baltimore, United States

Dana Farber Cancer Institute ( Site 0783)

Boston, United States

Munson Medical Center ( Site 0812)

Traverse City, United States

Morristown Memorial Hospital ( Site 0795)

Morristown, United States

Memorial Sloan Kettering Cancer Center ( Site 0832)

New York, United States

WakeMed Raleigh Campus ( Site 0811)

Raleigh, United States

TriHealth Cancer Institute-Good Samaritan Hospital ( Site 0822)

Cincinnati, United States

Cleveland Clinic - Ohio ( Site 0793)

Cleveland, United States

Fox Chase Cancer Center ( Site 0830)

Philadelphia, United States

The West Clinic, P.C. ( Site 0791)

Germantown, United States

Thompson Cancer Survival Center ( Site 0803)

Knoxville, United States

Tennessee Oncology, PLLC - Elliston Place Plaza Medical Oncology & Hematology ( Site 0831)

Nashville, United States

Virginia Oncology Associates (VOA) ( Site 8002)

Norfolk, United States

Fred Hutchinson Cancer Research Center ( Site 0787)

Seattle, United States

Hospital Italiano de Buenos Aires ( Site 0004)

Ciudad Autonoma de Buenos Aires, Argentina

Asociacion de Beneficencia Hospital Sirio Libanes ( Site 0003)

Ciudad Autonoma de Buenos Aires, Argentina

Instituto Alexander Fleming ( Site 0002)

Ciudad Autónoma de Buenos Aires, Argentina

Instituto de Oncologia de Rosario ( Site 0005)

Rosario, Argentina

Macquarie University ( Site 0031)

Macquarie, Australia

Mater Hospital Brisbane ( Site 0032)

South Brisbane, Australia

Cliniques Universitaires Saint-Luc ( Site 0062)

Brussels, Belgium

AZ Maria Middelares ( Site 0063)

Ghent, Belgium

UZ Gent ( Site 0064)

Ghent, Belgium

CHC Montlegia Clinic ( Site 0061)

Liège, Belgium

ICTRIALS Pesquisa e Desenvolvimento ( Site 0107)

Curitiba, Brazil

Hospital Moinhos de Vento ( Site 0102)

Porto Alegre, Brazil

Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0110)

São José do Rio Preto, Brazil

Hospital Alemao Oswaldo Cruz ( Site 0101)

São Paulo, Brazil

Princess Margaret Cancer Centre ( Site 0123)

Toronto, Canada

Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0121)

Québec, Canada

Peking University First Hospital ( Site 0184)

Beijing, China

The First Affiliated Hospital of Chonqing Medical University ( Site 0197)

Chongqing, China

Sun Yat-Sen University Cancer Center ( Site 0183)

Guangzhou, China

Sun Yat-Sen University Cancer Center ( Site 0188)

Guangzhou, China

Zhujiang Hospital of Southern Medical University ( Site 0205)

Guangzhou, China

Sun Yat-sen Memorial Hospital, Sun Yat-sen University-Urology Surgery ( Site 0189)

Guangzhou, China

The Fifth Affiliated Hospital of Sun Yat-Sen University ( Site 0900)

Zhuhai, China

Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 0198)

Wuhan, China

The Second Xiangya Hospital of Central South University ( Site 0916)

Changsha, China

Jiangsu Cancer Hospital ( Site 0917)

Nanjing, China

Jiangxi Cancer Hospital ( Site 0192)

Nanchang, China

Fudan University Shanghai Cancer Center ( Site 0181)

Shanghai, China

Zhongshan Hospital Fudan University ( Site 0907)

Shanghai, China

West China Hospital of Sichuan University ( Site 0185)

Chengdu, China

The Second Hospital of Tianjin Medical University ( Site 0910)

Tianjin, China

The First Hospital of Jiaxing ( Site 0901)

Jiaxing, China

The First Affiliated Hospital of Ningbo University ( Site 0193)

Ningbo, China

Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School ( Site 0186)

Wenzhou, China

The First Affiliated Hospital of Wenzhou Medical University ( Site 0194)

Wenzhou, China

CHRU de Brest ( Site 0272)

Brest, France

Charité Universitaetsmedizin Berlin - Campus Mitte ( Site 0304)

Berlin, Germany

General Oncology Hospital of Kifisia "Agioi Anargyroi" ( Site 0335)

Athens, Greece

METROPOLITAN GENERAL HOSPITAL-ONCOLOGIC CLINICAL TRIALS AND RESEARCH CLINIC ( Site 0332)

Athens, Greece

University General Hospital ''Attikon'' - General Hospital of West Attica "H AGIA VARVARA" ( Site 0333)

Chaïdári, Greece

Athens Medical Center ( Site 0336)

Marousi, Greece

European Interbalkan Medical Center ( Site 0331)

Thessaloniki, Greece

Rambam Health Care Campus ( Site 0362)

Haifa, Israel

Shaare Zedek Medical Center ( Site 0366)

Jerusalem, Israel

Rabin Medical Center ( Site 0364)

Petah Tikva, Israel

Sheba Medical Center ( Site 0361)

Ramat Gan, Israel

Yitzhak Shamir Medical Center. ( Site 0367)

Ẕerifin, Israel

Istituto Clinico Humanitas ( Site 0398)

Rozzano, Italy

Azienda Ospedaliera S. Luigi Gonzaga ( Site 0391)

Orbassano, Italy

Centro Ricerche Cliniche di Verona ( Site 0393)

Verona, Italy

Ospedale San Donato. Azienda Sanitaria Toscana Sud Est ( Site 0392)

Arezzo, Italy

IRCCS Azienda Ospedaliera Metropolitana ( Site 0394)

Genova, Italy

Fondazione IRCCS Istituto Nazionale Dei Tumori ( Site 0396)

Milan, Italy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 0397)

Roma, Italy

Nagoya University Hospital ( Site 0429)

Nagoya, Japan

Hirosaki University Hospital ( Site 0435)

Hirosaki, Japan

Ehime University Hospital ( Site 0430)

Tōon, Japan

Hokkaido University Hospital ( Site 0436)

Sapporo, Japan

Kobe University Hospital ( Site 0431)

Kobe, Japan

University of Tsukuba Hospital ( Site 0432)

Tsukuba, Japan

Kagawa University Hospital ( Site 0424)

Kita-gun, Japan

St. Marianna University Hospital ( Site 0422)

Kawasaki, Japan

Kitasato University Hospital ( Site 0425)

Sagamihara, Japan

Nara Medical University Hospital ( Site 0423)

Kashihara, Japan

Osaka Rosai Hospital ( Site 0428)

Sakai, Japan

Institute of Science Tokyo Hospital ( Site 0421)

Bunkyo, Japan

Cancer Institute Hospital of JFCR ( Site 0426)

Koto, Japan

Kyushu University Hospital ( Site 0434)

Fukuoka, Japan

Gifu University Hospital ( Site 0427)

Gifu, Japan

Kyoto University Hospital ( Site 0433)

Kyoto, Japan

Radboudumc ( Site 0487)

Nijmegen, Netherlands

Maastricht UMC+ ( Site 0483)

Maastricht, Netherlands

Nederlands Kanker Instituut - Antoni van Leeuwenhoek - NKI-AVL ( Site 0482)

Amsterdam, Netherlands

Elisabeth-TweeSteden Ziekenhuis ( Site 0489)

Tilburg, Netherlands

Isala, locatie Zwolle ( Site 0486)

Zwolle, Netherlands

Erasmus Medisch Centrum ( Site 0481)

Rotterdam, Netherlands

St. Antonius Ziekenhuis, locatie Utrecht ( Site 0488)

Utrecht, Netherlands

H. de Badalona Germans Trias I Pujol ( Site 0603)

Badalona, Spain

Hospital Universitario Marques de Valdecilla ( Site 0605)

Santander, Spain

Hospital Universitario Insular de Gran Canaria ( Site 0604)

Las Palmas de Gran Canaria, Spain

Hospital Universitario Ramon y Cajal ( Site 0606)

Madrid, Spain

Hospital Universitari Vall d Hebron ( Site 0607)

Barcelona, Spain

Hospital Clinico San Carlos ( Site 0608)

Madrid, Spain

Hospital Universitario 12 de Octubre ( Site 0602)

Madrid, Spain

Hospital Virgen del Rocio ( Site 0601)

Seville, Spain

Laenssjukhuset Ryhov ( Site 0632)

Jönköping, Sweden

Karolinska Universitetssjukhuset Solna ( Site 0631)

Stockholm, Sweden

Cambridge University Hospitals NHS Foundation Trust ( Site 0756)

Cambridge, United Kingdom

St Bartholomew's Hospital ( Site 0751)

London, United Kingdom

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/3/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.